Endometrial Dating Method Detects Individual Maturation Sequences During the Secretory Phase.

Endometrial dating endometrial receptivity estrogen receptor progesterone receptor window of implantation

Journal

In vivo (Athens, Greece)
ISSN: 1791-7549
Titre abrégé: In Vivo
Pays: Greece
ID NLM: 8806809

Informations de publication

Date de publication:
Historique:
received: 05 04 2020
revised: 16 04 2020
accepted: 27 04 2020
entrez: 2 7 2020
pubmed: 2 7 2020
medline: 22 6 2021
Statut: ppublish

Résumé

This study assessed whether a new immunohistochemical dating method allows precise endometrial dating allowing optimal timing for embryo transfer. A novel method was used for endometrial dating, with parameters including menstrual cycle days, Noyes histological criteria, along with immunohistochemical expression pattern of estrogen and progesterone receptors and proliferation marker Ki-67. Endometrial maturation was analyzed on days +5 to +10 after ovulation or progesterone administration in 217 biopsies from 151 subfertile patients during the secretory phase. Endometrial maturation varied individually, occurring 1.68±1.67 days late. Comparison of histological maturation with clinical days after ovulation showed a delay of about 2 days. Endometrial maturation requires 8 days, rather than the expected 6 days, to reach the histological mid-secretory phase. This is not a delay and is also seen in fertile patients. The new analysis method used is superior to that using Noyes criteria alone and provides a better basis for determining conditions for optimal timing of embryo transfers.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
This study assessed whether a new immunohistochemical dating method allows precise endometrial dating allowing optimal timing for embryo transfer.
PATIENTS AND METHODS METHODS
A novel method was used for endometrial dating, with parameters including menstrual cycle days, Noyes histological criteria, along with immunohistochemical expression pattern of estrogen and progesterone receptors and proliferation marker Ki-67. Endometrial maturation was analyzed on days +5 to +10 after ovulation or progesterone administration in 217 biopsies from 151 subfertile patients during the secretory phase.
RESULTS RESULTS
Endometrial maturation varied individually, occurring 1.68±1.67 days late. Comparison of histological maturation with clinical days after ovulation showed a delay of about 2 days.
CONCLUSION CONCLUSIONS
Endometrial maturation requires 8 days, rather than the expected 6 days, to reach the histological mid-secretory phase. This is not a delay and is also seen in fertile patients. The new analysis method used is superior to that using Noyes criteria alone and provides a better basis for determining conditions for optimal timing of embryo transfers.

Identifiants

pubmed: 32606167
pii: 34/4/1951
doi: 10.21873/invivo.11992
pmc: PMC7439867
doi:

Substances chimiques

Receptors, Progesterone 0
Progesterone 4G7DS2Q64Y

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1951-1963

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Références

Am J Obstet Gynecol. 1975 May;122(2):262-3
pubmed: 1155504
Br J Obstet Gynaecol. 1984 Jul;91(7):685-9
pubmed: 6743610
Proc R Soc Med. 1934 May;27(7):849-63
pubmed: 19989793
Hum Fertil (Camb). 2008 Sep;11(3):131-46
pubmed: 18766953
J Clin Endocrinol Metab. 2000 Nov;85(11):4207-11
pubmed: 11095455
J Clin Endocrinol Metab. 2008 Oct;93(10):4058-64
pubmed: 18647810
Fertil Steril. 2004 Nov;82(5):1264-72
pubmed: 15533340
Fertil Steril. 1993 Oct;60(4):652-7
pubmed: 8405519
Hum Reprod Update. 1998 Sep-Oct;4(5):539-49
pubmed: 10027607
Fertil Steril. 2006 Nov;86(5):1344-55
pubmed: 16978615
J Am Med Assoc. 1937 Jun 12;108(24):2022-8
pubmed: 12255649
Fertil Steril. 2011 Jan;95(1):50-60, 60.e1-15
pubmed: 20619403
Fertil Steril. 2004 May;81(5):1333-43
pubmed: 15136099
Fertil Steril. 2002 Jul;78(1):102-7
pubmed: 12095498
Fertil Steril. 2003 Apr;79(4):970-4
pubmed: 12749439
Int J Fertil. 1980;25(2):112-6
pubmed: 6117524
Fertil Steril. 1982 Nov;38(5):564-71
pubmed: 7128842
J Assist Reprod Genet. 2018 Jul;35(7):1301-1305
pubmed: 29737471
BJOG. 2009 Jan;116(2):304-12
pubmed: 19076963
Br J Obstet Gynaecol. 1992 May;99(5):422-9
pubmed: 1622917
Major Probl Obstet Gynecol. 1977;7:1-193
pubmed: 836520
Fertil Steril. 1988 Jul;50(1):52-60
pubmed: 3289976

Auteurs

Joachim Alfer (J)

Department of Pathology, Erlangen University Hospital, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany joachim.alfer@pathologie-ravensburg.de.
Kaufbeuren-Ravensburg Institute of Pathology, Ravensburg, Germany.

Amir Fattahi (A)

Department of Obstetrics and Gynecology, Erlangen University Hospital, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany.
Department of Reproductive Biology, School of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.

Nathalie Bleisinger (N)

Department of Obstetrics and Gynecology, Erlangen University Hospital, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany.

JÜrgen Krieg (J)

Fertility-Center Amberg, Amberg, Germany.

Rolf Behrens (R)

Centre for Reproductive Medicine, Erlangen, Germany.

Ralf Dittrich (R)

Department of Obstetrics and Gynecology, Erlangen University Hospital, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany.

Matthias W Beckmann (MW)

Department of Obstetrics and Gynecology, Erlangen University Hospital, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany.

Arndt Hartmann (A)

Department of Pathology, Erlangen University Hospital, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany.

Irmgard Classen-Linke (I)

Institute of Molecular and Cellular Anatomy, Medical Faculty, RWTH Aachen University, Aachen, Germany.

Roxana M Popovici (RM)

Fertility-Center Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH